{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T21:06:35Z","timestamp":1776805595481,"version":"3.51.2"},"reference-count":39,"publisher":"Impact Journals, LLC","issue":"67","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2017,12,19]]},"DOI":"10.18632\/oncotarget.22881","type":"journal-article","created":{"date-parts":[[2017,12,4]],"date-time":"2017-12-04T12:29:53Z","timestamp":1512390593000},"page":"111631-111641","source":"Crossref","is-referenced-by-count":21,"title":["Inhibition of tumor necrosis factor signaling attenuates renal immune cell infiltration in experimental membranous nephropathy"],"prefix":"10.18632","volume":"8","author":[{"given":"Yen-Sung","family":"Huang","sequence":"first","affiliation":[{"name":"Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shin-Huei","family":"Fu","sequence":"additional","affiliation":[{"name":"Graduate Institute of Microbiology and Immunology, National Defense Medical Center, Taipei, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuo-Cheng","family":"Lu","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan"},{"name":"Division of Nephrology, Department of Medicine, Fu Jen Catholic University Hospital, New Taipei City, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin-Shuen","family":"Chen","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hsin-Yi","family":"Hsieh","sequence":"additional","affiliation":[{"name":"Graduate Institute of Microbiology and Immunology, National Defense Medical Center, Taipei, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huey-Kang","family":"Sytwu","sequence":"additional","affiliation":[{"name":"Graduate Institute of Microbiology and Immunology, National Defense Medical Center, Taipei, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chia-Chao","family":"Wu","sequence":"additional","affiliation":[{"name":"Graduate Institute of Microbiology and Immunology, National Defense Medical Center, Taipei, Taiwan"},{"name":"Division of Nephrology, Department of Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2017,12,4]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/S0270-9295(03)00049-4","article-title":"Diagnosis and natural course of membranous nephropathy","volume":"23","author":"Glassock","year":"2003","journal-title":"Semin Nephrol"},{"key":"2","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1046\/j.1523-1755.2001.0590051983.x","article-title":"Idiopathic membranous glomerulonephritis","volume":"59","author":"Cattran","year":"2001","journal-title":"Kidney Int"},{"key":"3","doi-asserted-by":"crossref","first-page":"983","DOI":"10.2215\/CJN.11761116","article-title":"Primary Membranous Nephropathy","volume":"12","author":"Couser","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"key":"4","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1146\/annurev.me.39.020188.002505","article-title":"Pathogenesis of membranous nephropathy","volume":"39","author":"Abrass","year":"1988","journal-title":"Annu Rev Med"},{"key":"5","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1681\/ASN.2004121098","article-title":"Cellular response to injury in membranous nephropathy","volume":"16","author":"Couser","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"6","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1097\/01.mnh.0000222692.99711.02","article-title":"New insights into the pathogenesis of membranous glomerulonephritis","volume":"15","author":"Debiec","year":"2006","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"7","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1053\/j.ajkd.2005.08.020","article-title":"Idiopathic membranous nephropathy: outline and rationale of a treatment strategy","volume":"46","author":"Wetzels","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"8","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/S0272-6386(04)00868-6","article-title":"The treatment of idiopathic membranous nephropathy: a dilemma or a conundrum?","volume":"44","author":"Glassock","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"9","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1146\/annurev.iy.10.040192.002211","article-title":"The Pathophysiology of Tumor Necrosis Factors","volume":"10","author":"Vassalli","year":"1992","journal-title":"Annu Rev Immunol"},{"key":"10","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/01.mnh.0000437331.23794.81","article-title":"Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) and kidney disease","volume":"23","author":"Ramos","year":"2014","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"11","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/ki.2009.142","article-title":"Immunoregulatory role of TNFalpha in inflammatory kidney diseases","volume":"76","author":"Mayadas","year":"2009","journal-title":"Kidney Int"},{"key":"12","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/ki.2014.285","article-title":"TNF receptors: signaling pathways and contribution to renal dysfunction","volume":"87","author":"Mayadas","year":"2015","journal-title":"Kidney Int"},{"key":"13","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/sj.ki.5002054","article-title":"TNFA2 and d2 alleles of the tumor necrosis factor alpha gene polymorphism are associated with onset\/occurrence of idiopathic membranous nephropathy","volume":"71","author":"Berthoux","year":"2007","journal-title":"Kidney Int"},{"key":"14","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1159\/000090706","article-title":"Tumor necrosis factor-alpha gene G-308A polymorphism is a risk factor for the development of membranous glomerulonephritis","volume":"26","author":"Ivens","year":"2006","journal-title":"Am J Nephrol"},{"key":"15","doi-asserted-by":"crossref","first-page":"3948","DOI":"10.1093\/ndt\/gfq310","article-title":"Urinary excretion of soluble tumour necrosis factor receptor 1 as a marker of increased risk of progressive kidney function deterioration in patients with primary chronic glomerulonephritis","volume":"25","author":"Czekalski","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"16","doi-asserted-by":"crossref","first-page":"e104354","DOI":"10.1371\/journal.pone.0104354","article-title":"Circulating TNF receptors are significant prognostic biomarkers for idiopathic membranous nephropathy","volume":"9","author":"Lee","year":"2014","journal-title":"PloS One"},{"key":"17","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1093\/ndt\/gfn771","article-title":"Inhibition of tumour necrosis factor alpha in idiopathic membranous nephropathy: a pilot study","volume":"24","author":"Boletis","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"18","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1016\/S0140-6736(00)04830-3","article-title":"Use of pentoxifylline in membranous nephropathy","volume":"357","author":"Chalopin","year":"2001","journal-title":"Lancet"},{"key":"19","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1096\/fj.05-3841com","article-title":"TNFR1- and TNFR2-mediated signaling pathways in human kidney are cell type-specific and differentially contribute to renal injury","volume":"19","author":"Bradley","year":"2005","journal-title":"FASEB J"},{"key":"20","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1038\/ki.2014.330","article-title":"Elevation of circulating TNF receptors 1 and 2 increases the risk of end-stage renal disease in American Indians with type 2 diabetes","volume":"87","author":"Niewczas","year":"2015","journal-title":"Kidney Int"},{"key":"21","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/ki.2015.278","article-title":"Tumor necrosis factor receptors 1 and 2 are associated with early glomerular lesions in type 2 diabetes","volume":"89","author":"Krolewski","year":"2016","journal-title":"Kidney Int"},{"key":"22","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1172\/JCI200523348","article-title":"Renal cell-expressed TNF receptor 2, not receptor 1, is essential for the development of glomerulonephritis","volume":"115","author":"Mayadas","year":"2005","journal-title":"J Clin Invest"},{"key":"23","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1038\/nm1304","article-title":"Amelioration of inflammatory arthritis by targeting the pre-ligand assembly domain of tumor necrosis factor receptors","volume":"11","author":"Lenardo","year":"2005","journal-title":"Nat Med"},{"key":"24","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1126\/science.288.5475.2351","article-title":"A Domain in TNF Receptors That Mediates Ligand-Independent Receptor Assembly and Signaling","volume":"288","author":"Lenardo","year":"2000","journal-title":"Science"},{"key":"25","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1126\/science.283.5401.543","article-title":"Prevention of Constitutive TNF Receptor 1 Signaling by Silencer of Death Domains","volume":"283","author":"Goeddel","year":"1999","journal-title":"Science"},{"key":"26","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1681\/ASN.2006030192","article-title":"Therapeutic effect of anti-TNF-\u03b1 antibodies in an experimental model of anti-neutrophil cytoplasm antibody-associated systemic vasculitis","volume":"17","author":"Pusey","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"27","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1093\/ndt\/gfh832","article-title":"Development of glomerulonephritis during anti-TNF-alpha therapy for rheumatoid arthritis","volume":"20","author":"D'Agati","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"28","first-page":"840","article-title":"Membranous nephropathy in rheumatoid arthritis: a case report","volume":"27","author":"Cantatore","year":"2009","journal-title":"Clin Exp Rheumatol"},{"key":"29","first-page":"e62","article-title":"Membranous glomerulonephritis with the use of etanercept in ankylosing spondylitis","volume":"45","author":"Ellison","year":"2011","journal-title":"Ann Pharmacother"},{"key":"30","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.jaut.2011.05.013","article-title":"Targeting pre-ligand assembly domain of TNFR1 ameliorates autoimmune diseases - an unrevealed role in downregulation of Th17 cells","volume":"37","author":"Sytwu","year":"2011","journal-title":"J Autoimmun"},{"key":"31","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1136\/gutjnl-2013-306585","article-title":"Targeting tumour necrosis factor receptor 1 assembly reverses Th17-mediated colitis through boosting a Th2 response","volume":"64","author":"Sytwu","year":"2015","journal-title":"Gut"},{"key":"32","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.bbrc.2014.08.077","article-title":"Urinary Xist is a potential biomarker for membranous nephropathy","volume":"452","author":"Wu","year":"2014","journal-title":"Biochem Biophys Res Commun"},{"key":"33","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1007\/s10875-011-9614-7","article-title":"Pathogenic role of effector cells and immunoglobulins in cationic bovine serum albumin-induced membranous nephropathy","volume":"32","author":"Sytwu","year":"2012","journal-title":"J Clin Immunol"},{"key":"34","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1111\/j.1600-079X.2011.00960.x","article-title":"Melatonin enhances endogenous heme oxygenase-1 and represses immune responses to ameliorate experimental murine membranous nephropathy","volume":"52","author":"Sytwu","year":"2012","journal-title":"J Pineal Res"},{"key":"35","first-page":"581928","article-title":"Approaching biomarkers of membranous nephropathy from a murine model to human disease","volume":"2011","author":"Lin","year":"2011","journal-title":"J Biomed Biotechnol"},{"key":"36","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1258\/la.2007.06016e","article-title":"Experimental model of membranous nephropathy in mice: sequence of histological and biochemical events","volume":"42","author":"Lin","year":"2008","journal-title":"Lab Anim"},{"key":"37","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1038\/sj.ki.5002426","article-title":"Kinetics of adaptive immunity to cationic bovine serum albumin-induced membranous nephropathy","volume":"72","author":"Lin","year":"2007","journal-title":"Kidney Int"},{"key":"38","doi-asserted-by":"crossref","first-page":"e0125726","DOI":"10.1371\/journal.pone.0125726","article-title":"Resveratrol ameliorates renal damage, increases expression of heme oxygenase-1, and has anti-complement, anti-oxidative, and anti-apoptotic effects in a murine model of membranous nephropathy","volume":"10","author":"Sytwu","year":"2015","journal-title":"PloS One"},{"key":"39","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1056\/NEJMoa1013792","article-title":"Early-childhood membranous nephropathy due to cationic bovine serum albumin","volume":"364","author":"Ronco","year":"2011","journal-title":"N Engl J Med"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.22881","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T16:36:52Z","timestamp":1589215012000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.22881"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,4]]},"references-count":39,"journal-issue":{"issue":"67","published-print":{"date-parts":[[2017,12,19]]}},"alternative-id":["22881","29340080"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.22881","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,4]]}}}